Single-use Bioprocessing Probes & Sensors Market Size & Growth Forecast 2027–2036, By Segments (Workflow, End Use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Single-use Bioprocessing Probes & Sensors Market size was estimated at USD 3.99 billion in 2026 and is projected to grow at a 10.75% CAGR from 2027 to 2036, crossing USD 11.08 billion by 2036. The industry revenue for 2027 is assessed at USD 4.35 billion.
Get more details on this report
Request Free Sample ReportSingle-use Bioprocessing Probes & Sensors Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 45.38% market share in 2026, driven by its mature biopharmaceutical manufacturing base and widespread use of single-use monitoring technologies in production workflows.
- Asia Pacific is projected to grow at a 12.54% CAGR as expanding biomanufacturing capacity and greater adoption of single-use production systems increase demand for compatible monitoring solutions.
Segment Momentum
- Upstream accounted for a 70.52% market share in 2026 because continuous monitoring of cell culture conditions and process stability is essential for consistent biologics production using single-use technologies.
- CROs & CMOs are the fastest-growing end-use segment as outsourcing expands and flexible multi-client manufacturing increases demand for adaptable single-use monitoring systems that support rapid production changeovers.
Market Expansion Drivers
- Single-use technology adoption reducing contamination risks and improving biomanufacturing efficiency.
- Flexible scalable bioprocessing systems enabling rapid production adjustment and monitoring.
- Expansion of biologics and cell therapy pipelines increasing demand for advanced sensors.
Leading Market Participants
- Prominent players in the single-use bioprocessing probes & sensors market include Thermo Fisher Scientific Inc. (United States), Sartorius AG (Germany), Danaher Corporation (United States), Merck KGaA (Germany), Mettler-Toledo International Inc. (United States), Hamilton Company (United States), Parker Hannifin Corporation (United States), PreSens Precision Sensing GmbH (Germany), Saint-Gobain S.A. (France), Dover Corporation (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 3.99 billion
- 2027 Estimated Market Size: USD 4.35 billion.
- Projected Market Size: USD 11.08 billion by 2036
- Growth Forecast: 10.75% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Upstream (Workflow) | Biopharmaceutical Companies (End Use) | pH Sensor (Type)
- Emerging Opportunity Segment: Upstream (Workflow) | CROs & CMOs (End Use) | pH Sensor (Type)
Market Growth Drivers and Industry Trends
Single-use technology adoption reducing contamination risks and improving biomanufacturing efficiency
The increasing adoption of disposable bioprocessing technologies is encouraging manufacturers to replace reusable components with single-use systems that simplify production operations and reduce contamination concerns. This trend will drive the single-use bioprocessing probes & sensors market growth as single-use probes and sensors can be incorporated into disposable assemblies used throughout biomanufacturing workflows. Reduced requirements for cleaning, sterilization, and equipment changeover can streamline processing activities, while integrated sensing capabilities allow operators to monitor critical process conditions without introducing additional reusable components into production environments.
Flexible scalable bioprocessing systems enabling rapid production adjustment and monitoring
Biomanufacturers are placing greater emphasis on flexible production platforms that can be adjusted to accommodate changing batch requirements, product types, and manufacturing conditions. The single-use bioprocessing probes & sensors market will benefit from this shift because disposable monitoring components can be integrated into modular systems that support faster configuration changes and streamlined process control. Such flexibility is particularly relevant for facilities managing multiple products or variable production volumes, where adaptable monitoring solutions can help maintain consistent process oversight while limiting the operational complexity associated with fixed processing infrastructure.
Expansion of biologics and cell therapy pipelines increasing demand for advanced sensors
The continued development of biologic medicines and cell therapy products is increasing the complexity and monitoring requirements of modern biomanufacturing processes. Expansion of these pipelines will boost single-use bioprocessing probes & sensors market demand as manufacturers require reliable sensing technologies to monitor parameters such as temperature, pressure, dissolved gases, and other critical process conditions. Advanced sensors integrated into disposable bioprocessing systems can provide continuous process information while supporting the controlled manufacturing environments required for sensitive biological products.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Single-use technology adoption reducing contamination risks and improving biomanufacturing efficiency | 2.00% | High | North America, Europe | High | Near Term |
| Flexible scalable bioprocessing systems enabling rapid production adjustment and monitoring | 1.60% | High | Europe, Asia Pacific | High | Near Term |
| Expansion of biologics and cell therapy pipelines increasing demand for advanced sensors | 1.40% | High | North America, Asia Pacific | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the single-use bioprocessing probes & sensors market with a 45.38% share in 2026, supported by a mature biopharmaceutical manufacturing ecosystem and strong adoption of advanced process monitoring technologies. Single-use systems help bioprocessing facilities improve operational flexibility, reduce contamination risks, and streamline manufacturing workflows, making them increasingly valuable for modern biologics production. The region's established biopharmaceutical infrastructure, sophisticated manufacturing capabilities, and emphasis on process quality support consistent demand for disposable monitoring solutions. Continued movement toward flexible and scalable production processes is further strengthening the role of single-use probes and sensors in regional bioprocessing operations.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market, driven by expanding biopharmaceutical manufacturing capacity, modernization of life sciences infrastructure, and increasing adoption of advanced production technologies. Growing investment in biologics manufacturing is encouraging facilities to adopt process monitoring solutions that support quality, efficiency, and operational consistency. Single-use technologies are particularly relevant as manufacturers seek flexible production systems that can be scaled across different applications without extensive fixed infrastructure. Strengthening pharmaceutical manufacturing capabilities and rising interest in advanced bioprocessing approaches are creating favorable conditions for wider adoption across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
GMP precision monitoringGermany’s single-use bioprocessing probes and sensors market is shaped by highly regulated pharmaceutical manufacturing and strong emphasis on process precision. In Germany, manufacturers prioritize validated single-use systems for inline monitoring, ensuring compliance, reproducibility, and high-quality biologics production across industrial biotech facilities.
France 🇫🇷
Bioindustrial process complianceFrance’s single-use bioprocessing probes and sensors market is influenced by strong regulatory oversight and growing biomanufacturing investments. In France, adoption is centered on compliant, single-use monitoring systems that enhance process reliability and support vaccine and biologics production environments.
Italy 🇮🇹
Flexible biotech productionItaly’s single-use bioprocessing probes and sensors market is driven by increasing flexibility needs in biotech production and contract manufacturing operations. In Italy, companies favor disposable sensing solutions that reduce cleaning validation burdens and support agile production across emerging biopharmaceutical facilities.
Japan 🇯🇵
Regulated biologics efficiencyJapan’s single-use bioprocessing probes and sensors market is driven by expanding biologics production and strict regulatory expectations in pharmaceutical manufacturing. In Japan, companies adopt disposable sensing technologies to improve contamination control, streamline validation processes, and enhance operational efficiency in high-value drug production.
South Korea 🇰🇷
Biopharma capacity expansionSouth Korea’s single-use bioprocessing probes and sensors market is supported by rapid expansion of domestic biopharmaceutical manufacturing capacity. In South Korea, firms integrate single-use sensing systems to accelerate production scalability, support contract manufacturing growth, and maintain quality control in advanced biologics facilities.
United States 🇺🇸
Biopharma scale-up systemsUnited States single-use bioprocessing probes and sensors market is driven by large-scale biopharmaceutical manufacturing and continuous process optimization needs. In the U.S., adoption is concentrated in GMP-compliant facilities where disposable sensors support real-time monitoring, reduce contamination risk, and improve efficiency in biologics production workflows.
Segment Leadership and Growth Trends
Single-use Bioprocessing Probes & Sensors Market Share (%), by Workflow, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWorkflow Segment Analysis: Upstream (Largest & Fastest-Growing Segment)
The upstream segment accounted for the largest share of the single-use bioprocessing probes & sensors market in 2026 at 70.52% and also represented the fastest-growing segment. Its strong position reflects the critical role of real-time monitoring during cell culture, media preparation, and other early-stage bioprocessing activities, where accurate measurement of process conditions is essential for maintaining product quality and consistency. Increasing adoption of single-use manufacturing systems is further encouraging the integration of disposable probes and sensors that reduce contamination risks, simplify process changeovers, and support more flexible biomanufacturing operations.
End Use Segment Analysis: Biopharmaceutical Companies (Largest Segment) vs CROs & CMOs (Fastest-Growing Segment)
Biopharmaceutical companies held the largest share of the single-use bioprocessing probes & sensors market in 2026 at 44.16%, driven by extensive use of single-use technologies across research, development, and commercial bioprocessing activities. These organizations increasingly prioritize scalable manufacturing, contamination control, and flexible production workflows, creating sustained demand for sensors that enable reliable process monitoring without extensive cleaning and sterilization requirements. The expansion of biologics manufacturing and increasing emphasis on process automation further support adoption within biopharmaceutical facilities.
CROs & CMOs are experiencing faster growth as biopharmaceutical companies increasingly outsource research, development, and manufacturing activities to specialized service providers. These organizations require flexible and efficient processing capabilities to accommodate diverse projects while maintaining consistent quality and regulatory compliance. Single-use probes and sensors support rapid changeovers, reduce cross-contamination concerns, and simplify process operations, making them well suited to outsourced bioprocessing environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Workflow | Upstream, Downstream | Upstream | Upstream |
| End Use | Biopharmaceutical Companies, CROs & CMOs, Others | Biopharmaceutical Companies | CROs & CMOs |
| Type | pH Sensor, Oxygen Sensors, Pressure Sensors, Temperature Sensors, Conductivity Sensors, Flow Meter & Sensors, Others | pH Sensor | pH Sensor |
Competitive Landscape and Market Positioning
Leading companies in the single-use bioprocessing probes & sensors market:
1. Thermo Fisher Scientific Inc. (United States)
2. Sartorius AG (Germany)
3. Danaher Corporation (United States)
4. Merck KGaA (Germany)
5. Mettler-Toledo International Inc. (United States)
6. Hamilton Company (United States)
7. Parker Hannifin Corporation (United States)
8. PreSens Precision Sensing GmbH (Germany)
9. Saint-Gobain S.A. (France)
10. Dover Corporation (United States)
In the single-use bioprocessing probes & sensors market, development efforts are increasingly centered on improving measurement accuracy and integration within disposable processing environments. Continuous refinement of sensing technologies is enabling more reliable process monitoring across biomanufacturing workflows. New solution introductions are emerging with greater adaptability for varied production scales. The single-use bioprocessing probes & sensors market reflects a steady shift toward more flexible and contamination-reducing process intelligence systems.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Sartorius AG (Germany) | |||||||
| Danaher Corporation (United States) | |||||||
| Merck KGaA (Germany) | |||||||
| Mettler-Toledo International Inc. (United States) | |||||||
| Hamilton Company (United States) | |||||||
| Parker Hannifin Corporation (United States) | |||||||
| PreSens Precision Sensing GmbH (Germany) | |||||||
| Saint-Gobain S.A. (France) | |||||||
| Dover Corporation (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Aber Instruments | Nov-25 | Aber Instruments integrated its BioPAT Viamass biomass sensor into Sartorius Ambr 250 single-use vessels, expanding process analytical technology coverage across Sartorius’ bioreactor portfolio. The integration strengthens real-time monitoring capabilities in single-use bioprocessing workflows, improving process control and biomanufacturing efficiency. |
| Sartorius | Jun-25 | Sartorius completed a multi-year capacity expansion at its Aubagne headquarters in France, increasing output of fluid-management and bioprocessing technologies. The expansion enhances manufacturing scale for single-use system components, supporting growing demand for flexible and scalable bioprocessing infrastructure. |
| Thermo Fisher Scientific Inc. | Feb-24 | Thermo Fisher Scientific expanded its biologics manufacturing facility in St. Louis, Missouri, effectively doubling capacity from 2,000L to 5,000L. The expansion supports production of complex biologics targeting cancer, autoimmune diseases, and rare disorders, reinforcing upstream biomanufacturing capabilities linked to single-use bioprocessing demand. |
| Thermo Fisher Scientific Inc. | Feb-22 | Thermo Fisher Scientific invested USD 40 million to expand its single-use technology manufacturing site in Millersburg, Pennsylvania as part of a broader multi-year capacity program. The investment strengthens production capabilities for flexible bioprocessing components used in biologics and vaccine development, including COVID-19-related manufacturing support. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Single-use Bioprocessing Probes & Sensors Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Manufacturing Scale | Laboratory & Research Scale, Clinical Scale, Commercial Production Scale |
| Procurement Model | Direct Manufacturer Procurement, Distributor & Reseller Procurement, Integrated System Procurement |
| System Compatibility | Single-use Bioreactor Systems, Single-use Mixing & Storage Systems, Single-use Filtration Systems, Single-use Chromatography Systems |
Single-use Bioprocessing Probes & Sensors Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Single-use Technology Adoption in Biomanufacturing |
|
| Bioprocess Monitoring Workflow Transformation |
|
| Digital Bioprocessing Integration Potential |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the single-use bioprocessing probes & sensors market?
How is the single-use bioprocessing probes & sensors industry size expected to evolve during the forecast period?
How is single-use technology adoption transforming demand in bioprocessing probes and sensors?
How is the expansion of biologics and cell therapy pipelines influencing sensor requirements in bioprocessing?
Why does the Upstream workflow lead the single-use bioprocessing probes & sensors market?
Which end-use segment is growing the fastest in the single-use bioprocessing probes & sensors market?
Why is North America the largest market for single-use bioprocessing probes and sensors?
What factors are accelerating growth in the Asia Pacific single-use bioprocessing probes and sensors market?
Which companies are driving growth in the single-use bioprocessing probes & sensors landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization